Anti-LRRTM2 antibodies are used in the immunodetection of the protein leucine rich repeat transmembrane neuronal 2. In humans, the canonical protein has a reported length of 516 amino acid residues and a mass of 59.1 kDa. Its subcellular localization is in the cell membrane. It is reported to be expressed in neuronal tissues. A member of the LRRTM protein family, LRRTM2 is reported to be involved in development and maintenance of excitatory synapses in the vertebrate nervous system. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include leucine-rich repeat neuronal 2 protein, leucine-rich repeat transmembrane neuronal 2 protein, and leucine-rich repeat transmembrane neuronal protein 2. LRRTM2 gene orthologs have been reported in the mouse, rat, bovine, zebrafish, chimpanzee and chicken species. Some LRRTM2 antibodies may have been used in research and have associated citations. ELISA, Western Blot, Immunofluorescence, and Immunohistochemistry are common applications for these antibodies.